In a study from the Queen Mary University of London, scientists found there is convincing evidence that type 2 diabetes is linked to an increased risk of Parkinson’s disease.
They found that there was also evidence that type 2 diabetes may contribute to faster disease progression in patients who already have Parkinson’s.
Treating people with drugs already available for type 2 diabetes may reduce the risk and slow the progression of Parkinson’s. Screening for and early treatment of type 2 diabetes in patients with Parkinson’s may be advisable.
Previous studies have produced conflicting results around the link between diabetes and the risk of Parkinson’s disease.
This new study used a meta-analysis of observational data and genetic data to evaluate the effect of type 2 diabetes on the risk and progression of Parkinson’s disease.
The researchers say that this research brings together the results from many other studies to provide convincing evidence that type 2 diabetes likely affects not only Parkinson’s risk but also Parkinson’s progression.
There are many treatment strategies for type 2 diabetes, including prevention strategies, which may be re-purposed for the treatment of Parkinson’s.
If you care about diabetes, please read studies about new drugs to treat diabetes and metabolic syndrome, and heavy cannabis use may decrease the incidence of diabetes.
For more information about heart health, please see recent studies about the normal blood sugar for people with diabetes, and results showing Vitamin E may help prevent Parkinson’s disease.
The study was conducted by Dr. Alastair Noyce et al and published in Movement Disorders.
Copyright © 2022 Knowridge Science Report. All rights reserved.
